RxDoctor Payments Data

Edward Dubose, MD

Family Medicine · Sumter, SCNPI 1538145438

Payments from drug & device makers

$394in general payments, 2019–2025

Across 15 payments — averaging $26.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$139
  • Amgen$95
  • Mylan Specialty L.p.$43
  • Sanofi-aventis U.S. LLC$31
  • Melinta Therapeutics, LLC$28
  • Amarin Pharma, Inc.$23
  • plus $36 from 2 others

What the payments were for

  • Food & beverage$394100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$394 in reported general payments places this provider in the 45th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$57,534
Medicare patients
209
Services billed
1,348

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban221$97,650
TrulicityDulaglutide60$74,808
TivicayDolutegravir Sodium26$29,057
JanuviaSitagliptin Phosphate24$26,502
FarxigaDapagliflozin Propanediol19$22,004
OzempicSemaglutide11$20,721
EntrestoSacubitril/Valsartan27$20,024
XareltoRivaroxaban32$19,143
Janumet XrSitagliptin Phos/Metformin Hcl12$11,399
Breo ElliptaFluticasone/Vilanterol25$10,197
Atorvastatin Calcium629$7,017
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$6,714
Ezetimibe89$5,503
BrilintaTicagrelor11$4,938
SymbicortBudesonide/Formoterol Fumarate15$4,901

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$139$20,72111 claims
Johnson & JohnsonXarelto$13$19,14332 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Sumter

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →